KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hims & Hers Health (HIMS) EPS (Weighted Average and Diluted) (2019 - 2025)

Hims & Hers Health's EPS (Weighted Average and Diluted) history spans 7 years, with the latest figure at $0.08 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 20.0% year-over-year to $0.08; the TTM value through Dec 2025 reached $0.51, down 3.77%, while the annual FY2025 figure was $0.51, 3.77% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $0.08 at Hims & Hers Health, up from $0.06 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.32 in Q3 2024 and bottomed at -$0.34 in Q1 2021.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.04 (2023), against an average of -$0.0.
  • The largest annual shift saw EPS (Weighted Average and Diluted) crashed 100.0% in 2021 before it skyrocketed 900.0% in 2024.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.16 in 2021, then soared by 68.75% to -$0.05 in 2022, then soared by 120.0% to $0.01 in 2023, then surged by 900.0% to $0.1 in 2024, then dropped by 20.0% to $0.08 in 2025.
  • Per Business Quant, the three most recent readings for HIMS's EPS (Weighted Average and Diluted) are $0.08 (Q4 2025), $0.06 (Q3 2025), and $0.17 (Q2 2025).